Cancer cells often heterogeneously respond to genotoxic chemotherapy, leading to 15 fractional killing and chemoresistance 1, 2 , which remain as the major obstacles in cancer 16 treatment. It is widely believed that DNA damage induces a uniform response in regulating 17 transcription and that cell fate is passively determined by a threshold mechanism 18 evaluating the level of transcriptional responses 3 . On the contrary to this assumption, here 19 we show that a surprisingly high level of heterogeneity exists in individual cell 20 transcriptome responses to DNA damage, and that these transcriptome variations dictate 21 the cell fate after DNA damage. Many DNA damage response genes, including tumor 22 suppressor p53 targets, were exclusively expressed in only a subset of cells having specific 23 cell fate, producing unique stress responses tailored for the fate that the cells are 24 committed to. For instance, CDKN1A, the best known p53 target inhibiting cell cycle, was 25 specifically expressed in a subset of cells undergoing cell cycle checkpoint, while other pro-26 apoptotic p53 targets were expressed only in cells undergoing apoptosis. A small group of 27 cells exhibited neither checkpoint nor apoptotic responses, but produced a unique 28 transcriptional program that conferred strong chemoresistance to the cells. The 29 heterogeneous transcriptome response to DNA damage was also observed at the protein 30 level in flow cytometry. Our results demonstrate that cell fate heterogeneity after DNA 31 damage is mediated by distinct transcriptional programs generating fate-specific gene 32 expression landscapes. This finding provides an important insight into understanding 33 heterogeneous chemotherapy responses of cancer cells.
To address these questions, we performed Drop-seq 7 and determined a total of 10,421 single cell 45 transcriptome profiles from three different colon cancer cell lines: RKO, HCT116 and SW480. 46 These cells were either untreated or treated with different doses of a genotoxic chemical 5-47 fluorouracil (5FU), in 10 independent Drop-seq experiments (Extended Data Fig. 1a, b ). In 48 principal component analysis (PCA), t-distributed stochastic neighbor embedding (t-SNE), and 49 uniform manifold approximation and projection (UMAP) 8 , different cell lines displayed distinct 50 transcriptomic phenotypes (Extended Data Fig. 1c ). For all of these cell lines, 5FU-treated cells 51 were clustered in locations that were distinct from untreated cells (Extended Data Fig. 1d, e ), 52 indicating that the 5FU-induced DNA damage altered single cell transcriptomes. Indeed, 5FU 53 regulated formerly known DNA damage response genes, although the level and frequency of 54 regulation were different across the cell lines (Extended Data Fig. 1f-h) . 55 Using the RKO dataset, which exhibited the most robust DNA damage response from our dataset 56 (Extended Data Fig. 1f-h) , we explored the heterogeneity of single cell transcriptome profiles 57 with high-dimensional clustering. We identified four major clusters of cells (Fig. 1e , f and 58 Extended Data Fig. 2a ), where one cluster (group 0; n = 1,597) mainly consists of untreated 59 samples, while the other three clusters (groups 1, 2 and 3; n = 800, 571 and 85, respectively) 60 correspond to 5FU-treated samples (Fig. 1g, h) . Each of the three 5FU-treated clusters (groups 1-61 3) was found in all doses and batches (Fig. 1g, h and Extended Data Fig. 2b-e ), indicating that 62 these clustering results are not simply based on dose-or batch-specific effects. 63 The top 30 genes specifically expressed in each group were isolated through differential 64 expression analysis (Extended Data Table 1 ). Each of the 5FU-treated groups has a unique subset To further substantiate these observations, we performed the DNA content analysis through flow 88 cytometry. As predicted, 5FU treatment induced strong accumulation of a sub-G1 population, 89 which is suggestive of cell death (Fig. 2c ). The 5FU-treated cell population was partitioned into 90 the CCNE2-high CDKN1A-low group 1 and the CCNE2-low CDKN1A-high group 2, based on 91 their flow cytometry profiles (Fig. 2d, left) . These two groups of cells exhibit different forward 92 versus side scatter analyses values, indicating that their cell size and internal complexity are 93 different from each other (Extended Data Fig. 3d ). Roughly half of the group 1 cells appear as 94 sub-G1 (Fig. 2d, center) , indicating that this group contain many dying cells. Analyses with 95 active caspase-3 further confirmed that all cells in the CCNE2-high group 1 indeed have 96 activated apoptotic caspase cascade ( Fig. 2e ). In contrast, group 2 did not have sub-G1 cells ( Fig.   97 2d, center) and expressed relatively low levels of active caspase 3 ( Fig. 2e ), indicating that they 98 are protected from apoptosis. Group 2 cells instead exhibited strong G1 arrest in both flow 99 cytometry ( Fig. 2d , center) and scRNA-seq ( Fig. 2f, g) analyses. These results demonstrate that 100 the group 1 cells were indeed undergoing apoptosis while the group 2 cells experience cell cycle 101 arrest, as suggested by the gene ontology study ( Fig. 2b ). Although groups 1 and 2 exhibited 102 different cell fate phenotypes, they experienced similar levels of DNA damage, as assessed by 103 the γ-H2AX expression ( Fig. 2h ).
104
As 5FU dose becomes higher, the number of group 1 cells from the scRNA-seq dataset was 105 strongly decreased (Extended Data Fig. 2c-e ), although this pattern was not observed in flow 106 cytometry (Extended Data Fig. 3a ). It is possible that high levels of DNA damage accelerated 107 apoptotic progression of the group 1 cells, producing apoptosis-associated RNA decay 11 . 108 Therefore, even though the number of cells in the group 1 were high in flow cytometry ( Fig. 3a) , 109 they would not be represented in the scRNA-seq data (Extended Data Fig. 2c-e ). 110 The group 3 is a unique group of cells that is small but consistently detected in all experiments 111 regardless of 5FU doses. Unlike group 1 cells, the abundance of group 3 cells did not decrease 112 after high-dose 5FU treatments (Extended Data Fig. 2c-e ). Also unlike group 2 cells, the group 3 113 cells did not undergo cell cycle arrest ( Fig. 2f , g); therefore, group 3 cells seem to have evaded 114 both apoptosis and cell cycle checkpoint responses. As the group 3 cells express high levels of 115 genes mediating stress response, such as ATF3, FOS and DDIT3 (Extended Data Fig. 4a, b) , it is 116 likely that they represent a novel fate of chemoresistance. Group 3-like cells were also identified 117 from flow cytometry as CCNE2-low and ATF3/FOS-high cells (Extended Data Fig. 4c-f ). 118 Consistent with the notion that p53 pathway is central to cellular DNA damage response, all 119 5FU-treated groups identified the p53 signaling pathway as the top Kyoto Encyclopedia of 120 Genes and Genomes (KEGG) 12 pathway enriched in each group (Fig. 3a ). However, intriguingly, 121 a vast majority (93%) of these marker genes were exclusively found in a single group, and even 122 the remaining three genes (MDM2, GADD45A and RRM2B; 7%) were found only in two groups 123 but not in the third ). For instance, MDM2, a well-124 characterized negative feedback regulator of p53, was very highly expressed in the groups 2 and 125 3, but not in the group 1 ( Fig. 3c, d ; pink boxes). In contrast, ISG15, a recently identified positive 126 feedback regulator of p53 13 , was highly expressed only in the group 1, but not in the groups 2 127 and 3 ( Fig. 3b ; yellow box). It is possible that ISG15-mediated positive feedback in group 1 cells 128 allowed for sustained p53 activation 13 , leading to higher p53 activity and apoptotic cell death 14 . 129 MDM2-mediated negative feedback in group 2 and 3 cells may have produced pulse responses in 130 p53 activities 15 , inducing non-apoptotic consequences of limited p53 activation 14 . 131 Using a recently assembled list of p53 target genes 16 , we systematically investigated the 5FU-132 dependent p53 target activation in different groups of cells. For most of the p53 targets, 5FU-133 induced expression was higher in the groups 1 and 3 than in the group 2 ( Fig. 3e ). For instance, 134 many pro-apoptotic p53 target genes, such as PMAIP1, FAS and IKBIP, were highly expressed 135 in the group 1 ( Fig. 3f and Extended Data 6), and p53 target genes important for stress resistance, 136 such as ATF3, XPC and SESN1-3, were most distinctly expressed in the group 3 ( Fig. 3g and   137 Extended Data 5c, f). Only a small number of genes, such as CDKN1A and MDM2, were 138 expressed highly in group 2, compared to the other groups (Fig. 3f , g and Extended Data 6). 139 Therefore, even though all 5FU-treated groups generally up-regulated p53 pathway genes, they 140 induced a different subset of genes. 141 These results provide clear and convincing answers to all the questions we initially raised ( 
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Drop-seq and library preparation. We performed Drop-seq through the described protocol 325 (Macosko et al., 2015) . We mixed equal numbers of cells from three different cell lines 326 (approximately 40,000 cells for each cell line) for one loading of 120,000 cells for Drop-seq. 327 Briefly, three pump-controlled syringes with cell suspension (100,000 cells/ml, total 1.2 ml per 328 run), barcoded beads (Chemgenes, MACOSKO-2011-10) for each sample were merged across 10 batches, and the merged genotype likelihoods were used 385 to confirm the identity of droplets using popscle demuxlet. 11,259 droplets were confidently 386 inferred as singlets in both freemuxlet and demuxlet and used for the subsequent analysis. In the 387 downstream analysis (see below), droplets containing aberrantly high content of mitochondrial 388 mRNAs were further eliminated ( Figure S1A, right) ; therefore, the number of droplets actually 389 used for the analysis was reduced to 10,421 ( Figure S1A, left) . The digital expression matrix of 390 these droplets was produced using popscle plp-make-dge-matrix, using the same gene annotation 391 database (in GTF format) used for DropSeqTools.
392
Cell clustering and data visualization. The digital expression matrix was processed to Seurat 393 v3 22 following the "standard processing workflow" in the tutorial, except for a few changes. 394 First, we used 11% (RKO and SW480) and 21% (HCT116) as the threshold to filter out droplets 395 with aberrantly high mitochondrial reads based on the cell line-specific inspection of QC metrics 396 ( Figure S1A, right 
